Francis Medical key facts
as of Oct 2026- Developer of novel treatment devices designed to treat cancer in the prostate gland, urinary bladder, and kidney.
- Francis Medical is valued at approximately $230.0M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $160.0M across 2 recorded rounds; the latest was Early Stage VC ($40.0M) in Dec 2024.
- Notable investors include Arboretum Ventures, Boston Scientific Ventures, CHK Cleveland Tonkawa, Coloplast, H2Oey Ventures — 8 tracked in total.
- Francis Medical has filed 2 Form Ds with the SEC since 2021, most recently Dec 2024 ($40.0M sold to 16 investors).
- Status: Privately Held (backing).
Valued at $230.0M at its later-stage round, Dec 2024. Nothing has traded since.
- ·Watch Francis Medical: the Monday email on marks, rounds and moves
Francis Medical funding rounds
2 roundsFrancis Medical valuation
Francis Medical was valued at $230 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Francis Medical raised?
Francis Medical has raised $160 million in total; 2 of its rounds are on record. The largest on record was a $40 million early-stage round in Dec 2024.
Francis Medical has filed 2 Form Ds with the SEC since 2021, most recently in Dec 2024 ($40 million sold to 16 investors).
Francis Medical investors
8 investors are on record for Francis Medical, including Arboretum Ventures, Boston Scientific Ventures, CHK Cleveland Tonkawa and Coloplast. The early-stage round in Dec 2024 drew 16 investors.
About Francis Medical
Developer of novel treatment devices designed to treat cancer in the prostate gland, urinary bladder, and kidney. The company's devices are based on water vapor technology that is being explored for treating a variety of endourological cancers using the energy stored in a few drops of water to ablate cancerous tissue, enabling medical professionals to not only treat cancerous tissue but also protect surrounding structures to reduce the likelihood of the life-altering side effects common with other treatments.
- Sector
- Healthcare
- HQ
- Maple Grove, MN, United States
- Founded
- 2018
- Employees
- 48
- Website
- francismedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.